星昊医药
(920017)
| 流通市值：24.57亿 | | | 总市值：24.90亿 |
| 流通股本：1.23亿 | | | 总股本：1.25亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 514,863,960.6 | 517,217,031.99 | 491,298,314.64 | 465,947,571.03 |
| 交易性金融资产 | 317,720,408.18 | 277,354,613.68 | 301,965,989.03 | 271,525,027.41 |
| 应收票据及应收账款 | 88,885,403.12 | 77,001,805.71 | 82,063,645.07 | 85,668,258.01 |
| 其中：应收票据 | 16,371,322.36 | 7,185,562.27 | 15,663,675.45 | 14,242,031.28 |
| 应收账款 | 72,514,080.76 | 69,816,243.44 | 66,399,969.62 | 71,426,226.73 |
| 应收款项融资 | 3,962,933.54 | 1,456,652.92 | 8,788,835.27 | 5,562,841.97 |
| 预付款项 | 4,019,616.12 | 2,313,187.28 | 6,669,725.9 | 3,092,607.37 |
| 其他应收款合计 | 5,469,656.74 | 6,193,566.77 | 6,335,847.9 | 6,570,574.1 |
| 存货 | 66,544,923.19 | 62,516,746.41 | 60,751,055.24 | 58,167,216.7 |
| 一年内到期的非流动资产 | 64,402,849.25 | 21,508,383.49 | 21,353,808.15 | - |
| 其他流动资产 | 12,373,477.49 | 10,326,874.63 | 6,708,150.17 | 15,855,095.53 |
| 流动资产合计 | 1,078,243,228.23 | 975,888,862.88 | 985,935,371.37 | 912,389,192.12 |
| 非流动资产: | | | | |
| 长期股权投资 | 3,989,899.42 | 4,690,405.92 | 7,734,382.96 | 7,964,083.48 |
| 其他权益工具投资 | 5,957,845.68 | 5,957,845.68 | 10,820,153.45 | 10,820,153.45 |
| 固定资产 | 619,763,657.45 | 628,484,946.36 | 636,294,803.41 | 646,509,366.99 |
| 在建工程 | 120,711,863.14 | 110,353,347.49 | 94,043,687.92 | 67,031,884.87 |
| 无形资产 | 72,010,455.59 | 72,779,158.49 | 73,350,694.31 | 75,062,511.01 |
| 长期待摊费用 | - | - | 34,403.67 | 68,807.34 |
| 递延所得税资产 | 26,173,597.05 | 28,760,862.75 | 26,376,268.38 | 28,651,491.22 |
| 其他非流动资产 | 28,424,792.71 | 61,842,002.91 | 59,071,619.15 | 97,816,390.91 |
| 非流动资产合计 | 877,032,111.04 | 912,868,569.6 | 907,726,013.25 | 933,924,689.27 |
| 资产总计 | 1,955,275,339.27 | 1,888,757,432.48 | 1,893,661,384.62 | 1,846,313,881.39 |
| 流动负债: | | | | |
| 短期借款 | 10,008,555.56 | 10,008,555.56 | 10,008,555.56 | 10,008,555.56 |
| 应付票据及应付账款 | 77,778,510.2 | 99,715,244.31 | 86,747,239.54 | 50,212,680.78 |
| 其中：应付票据 | 40,845,350 | 58,673,770.76 | 49,988,070.76 | 18,519,570 |
| 应付账款 | 36,933,160.2 | 41,041,473.55 | 36,759,168.78 | 31,693,110.78 |
| 合同负债 | 28,841,709.1 | 28,010,904.64 | 30,920,097.82 | 33,792,769.6 |
| 应付职工薪酬 | 6,327,083.87 | 6,298,220.62 | 6,719,040.56 | 11,853,152.15 |
| 应交税费 | 7,954,984.46 | 5,031,072.55 | 3,943,706.26 | 5,591,888.91 |
| 其他应付款合计 | 50,854,619.92 | 50,283,538.29 | 46,401,054.18 | 50,635,750.2 |
| 其他流动负债 | 17,756,310.95 | 7,371,058.27 | 16,089,153.05 | 11,929,796.02 |
| 流动负债合计 | 199,521,774.06 | 206,718,594.24 | 200,828,846.97 | 174,024,593.22 |
| 非流动负债: | | | | |
| 预计负债 | 30,000,000 | 30,000,000 | 30,000,000 | 30,000,000 |
| 递延收益 | 88,600,196.14 | 93,117,176.23 | 97,634,156.43 | 102,151,136.59 |
| 递延所得税负债 | 1,720,005.56 | 1,776,377.87 | 1,897,295.16 | 1,869,182.71 |
| 非流动负债合计 | 120,320,201.7 | 124,893,554.1 | 129,531,451.59 | 134,020,319.3 |
| 负债合计 | 319,841,975.76 | 331,612,148.34 | 330,360,298.56 | 308,044,912.52 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 124,961,200 | 122,288,200 | 122,288,200 | 122,288,200 |
| 资本公积 | 747,085,990.81 | 716,640,520.81 | 715,174,556.03 | 715,174,556.03 |
| 减:库存股 | 15,565,242.81 | 15,565,242.81 | 15,565,242.81 | 15,565,242.81 |
| 其他综合收益 | -3,604,741.8 | -3,604,647.84 | 653,527.39 | 652,507.11 |
| 盈余公积 | 49,958,365.39 | 49,958,365.39 | 49,958,365.39 | 49,958,365.39 |
| 未分配利润 | 732,597,791.92 | 687,428,088.59 | 690,791,680.06 | 665,760,583.15 |
| 归属于母公司股东权益合计 | 1,635,433,363.51 | 1,557,145,284.14 | 1,563,301,086.06 | 1,538,268,968.87 |
| 少数股东权益 | - | - | - | 0 |
| 股东权益合计 | 1,635,433,363.51 | 1,557,145,284.14 | 1,563,301,086.06 | 1,538,268,968.87 |
| 负债和股东权益合计 | 1,955,275,339.27 | 1,888,757,432.48 | 1,893,661,384.62 | 1,846,313,881.39 |
| 公告日期 | 2025-10-28 | 2025-08-08 | 2025-04-28 | 2025-04-23 |
| 审计意见(境内) | | | | 标准无保留意见 |